Cetera Trust Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.6K Hold
746
– – 0.02% 237
2026
Q2
$31.8K Hold
746
– – 0.02% 242
2026
Q1
$46.8K Hold
746
– – 0.03% 221
2025
Q4
$71.1K Hold
746
– – 0.04% 208
2025
Q3
$72.8K Hold
746
– – 0.04% 211
2025
Q2
$80.1K Hold
746
– – 0.05% 210
2025
Q1
$75.3K Hold
746
– – 0.05% 209
2024
Q4
$66.6K Hold
746
– – 0.04% 210
2024
Q3
$62.5K Hold
746
– – 0.04% 224
2024
Q2
$57.4K Hold
746
– – 0.04% 222
2024
Q1
$51.1K Hold
746
– – 0.03% 230
2023
Q4
$43.1K Hold
746
– – 0.03% 233

Other funds holding BSX

Cetera Trust Company's BSX Position: Q3 2026 in Review

Cetera Trust Company held its Boston Scientific (BSX) position steady in Q3 2026 at 746 shares worth $32.6K. The position accounts for 0.02% of the portfolio, ranked #237.

Cetera Trust Company first reported a position in BSX in Q4 2023 and has held it in 12 quarters since. The position peaked at $80.1K in Q2 2025. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Cetera Trust Company held 746 shares of Boston Scientific worth $32.6K as of Q3 2026.
  • Cetera Trust Company left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up 0.02% of Cetera Trust Company's portfolio in Q3 2026, its #237 holding.
  • Cetera Trust Company first reported a position in Boston Scientific in Q4 2023 and has held it in 12 quarters since.
  • Cetera Trust Company's Boston Scientific position peaked at $80.1K in Q2 2025.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.